134 related articles for article (PubMed ID: 10471568)
1. Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.
Kaatz GW; Seo SM; Foster TJ
Antimicrob Agents Chemother; 1999 Sep; 43(9):2222-4. PubMed ID: 10471568
[TBL] [Abstract][Full Text] [Related]
2. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
[TBL] [Abstract][Full Text] [Related]
3. NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations.
Sun L; Sreedharan S; Plummer K; Fisher LM
Antimicrob Agents Chemother; 1996 Jul; 40(7):1665-9. PubMed ID: 8807059
[TBL] [Abstract][Full Text] [Related]
4. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA.
Muñoz-Bellido JL; Alonzo Manzanares M; Martínez Andrés JA; Guttiérrez Zufiaurre MN; Ortiz G; Segovia Hernández M; García-Rodríguez JA
Antimicrob Agents Chemother; 1999 Feb; 43(2):354-6. PubMed ID: 9925531
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus.
Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1997 Dec; 41(12):2733-7. PubMed ID: 9420048
[TBL] [Abstract][Full Text] [Related]
6. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter.
Kaatz GW; Thyagarajan RV; Seo SM
Antimicrob Agents Chemother; 2005 Jan; 49(1):161-9. PubMed ID: 15616291
[TBL] [Abstract][Full Text] [Related]
7. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
Kaatz GW; Seo SM; Ruble CA
Antimicrob Agents Chemother; 1993 May; 37(5):1086-94. PubMed ID: 8517696
[TBL] [Abstract][Full Text] [Related]
8. Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones.
Guirao GY; Martínez Toldos MC; Mora Peris B; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; Martínez Andrés JA; Muñoz Bellido JL; García-Rodríguez JA; Segovia Hernández M
J Antimicrob Chemother; 2001 Feb; 47(2):157-61. PubMed ID: 11157899
[TBL] [Abstract][Full Text] [Related]
9. Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
Schmitz FJ; Hertel B; Hofmann B; Scheuring S; Verhoef J; Fluit AC; Heinz HP; Köhrer K; Jones ME
J Antimicrob Chemother; 1998 Oct; 42(4):561-3. PubMed ID: 9818767
[No Abstract] [Full Text] [Related]
10. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
Aeschlimann JR; Kaatz GW; Rybak MJ
J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
[TBL] [Abstract][Full Text] [Related]
11. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
Ng EY; Trucksis M; Hooper DC
Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the nucleotide sequence and expression of norA genes and microbial susceptibility in 21 strains of Staphylococcus aureus.
Noguchi N; Okada H; Narui K; Sasatsu M
Microb Drug Resist; 2004; 10(3):197-203. PubMed ID: 15383162
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus.
Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ
Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus.
Truong-Bolduc QC; Ding Y; Hooper DC
J Bacteriol; 2008 Nov; 190(22):7375-81. PubMed ID: 18805983
[TBL] [Abstract][Full Text] [Related]
15. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.
Ubukata K; Itoh-Yamashita N; Konno M
Antimicrob Agents Chemother; 1989 Sep; 33(9):1535-9. PubMed ID: 2817852
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter.
Neyfakh AA; Borsch CM; Kaatz GW
Antimicrob Agents Chemother; 1993 Jan; 37(1):128-9. PubMed ID: 8431010
[TBL] [Abstract][Full Text] [Related]
17. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
18. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.
Truong-Bolduc QC; Zhang X; Hooper DC
J Bacteriol; 2003 May; 185(10):3127-38. PubMed ID: 12730173
[TBL] [Abstract][Full Text] [Related]
19. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Markham PN; Westhaus E; Klyachko K; Johnson ME; Neyfakh AA
Antimicrob Agents Chemother; 1999 Oct; 43(10):2404-8. PubMed ID: 10508015
[TBL] [Abstract][Full Text] [Related]
20. A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus.
Fournier B; Truong-Bolduc QC; Zhang X; Hooper DC
J Bacteriol; 2001 Apr; 183(7):2367-71. PubMed ID: 11244079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
